1 May 2024 in Journal of Inflammation Research
GDF-15 is an essential member of the transforming growth factor-beta superfamily. Its functions mainly involve in tissue injury, inflammation, fibrosis, regulation of appetite and weight, development of tumor, and cardiovascular disease. GDF-15 is involved in various signaling pathways, such as MAPK pathway, PI3K/AKT pathway, STAT3 pathway, RET pathway, and SMAD pathway. In addition, several factors such as p53, ROS, and TNF-α participate the regulation of GDF-15. However, the specific mechanism of these factors regulating GDF-15 is still unclear and more research is needed to explore them. GDF-15 mainly improves the function of kidneys in CKD and plays an important role in the prediction of CKD progression and cardiovascular complications. In addition, the role of GDF-15 in the kidney may be related to the SMAD and MAPK pathways. However, the specific mechanism of these pathways remains unclear. Accordingly, more research on the specific mechanism of GDF-15 affecting kidney disease is needed in the future. In conclusion, GDF-15 may be a therapeutic target for kidney disease.
6 June 2025 in Journal of the Renin-Angiotensin-Aldosterone System
Background: While the 1 mg dexamethasone suppression test (DST) is commonly used to diagnose mild autonomous cortisol secretion (MACS), the diagnostic utility of 24-h urinary free cortisol (24-h UFC) in patients with primary aldosteronism (PA) remains unclear. Methods: We prospectively enrolled 274 patients with confirmed PA between January 2017 and January 2020. MACS was defined by a post-DST serum cortisol level >1.8 μg/dL. Results: Among 274 PA patients (42.3% male; mean age, 55.9 ± 11.7 years)), 74 patients (27%) with PA had concomitant MACS while the other 200 patients were not. PA patients concomitant MACS were associated with higher 24-h UFC (OR, 1.91 [95% CI, 1.06–3.41], P = 0.03), older age (OR, 1.04 [95% CI, 1.01–1.07], P = 0.008), and diabetes mellitus (OR, 2.4 [95% CI, 1.12–5.12], P = 0.025). The 24-h UFC above 36 μg was associated with a positive predictive value of 32.6% and a negative predictive value of 77.9% for identifying concomitant MACS. Conclusions: Our study suggested the 24-h UFC less than 36 μg could help exclude MACS in PA cases. Combining this with 1 mg DST enhances accuracy. Additionally, older age and diabetes mellitus were also risk factors for predicting patients with PA concomitant MACS.